Even if clinical trials suggest tolerability, the real-world risk profile changes when: the source and purity of the peptide are uncertain, its used in different routes than studied, its used in stacked protocols with other drugs, its used in populations the trials didnt represent
I go into detail on the two most common oral B12 supplements, Methylcobalamin and Cyanocobalamin, in my Youtube video here: Ive found that most older patients prefer oral supplements over regular vitamin B12 injections, which is understandable
fixed heart rate (cardiovascular autonomic neuropathy) Entrapment / Mononeuropathy-Specific Carpal tunnel: nocturnal hand paresthesias, thenar atrophy, positive Tinel/Phalen signs Ulnar neuropathy: ring/little finger numbness, intrinsic weakness, claw hand Peroneal neuropathy: foot drop, steppage gait Sciatic neuropathy: posterior thigh/leg pain, weakness of knee flexion and all distal muscles Meralgia paresthetica: anterolateral thigh burning/numbness, no motor deficit CDI Query Trigger When documentation records peripheral neuropathy in a patient with Type 2 diabetes mellitus, query for diabetic etiology linkage
The goal is to get the peptide as close to the target tissue as possible, since BPC-157 acts primarily locally
